Regulations.gov document

PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan

Other · FDA-2007-D-0369 · posted Aug 22, 2023

Key facts

Document ID FDA-2007-D-0369-0915
Title PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan
Document type Other
Subtype Guidance
Agency FDA
Docket FDA-2007-D-0369
Posted Aug 22, 2023
Comment period opens Aug 22, 2023
Comments due Oct 24, 2023

At a glance

  • No Open for comment
  • 100–999 Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents